Future studies using METTL3 catalytic mutants, RNA immunoprecipitation followed by sequencing (RIP-seq), or transcriptome-wide m6A profiling (MeRIP-seq) will be essential to distinguish m6A-dependent from m6A-independent functions of METTL3 in migraine. Here, METTL3 is linked to migraine disorder.